Manufacturer prices are national. What varies by state is whether anyone else pays them
Medicaid coverage of the obesity indication is a state-by-state decision, and many programmes cover GLP-1s for diabetes while excluding obesity.
The most common question in this category — what does a GLP-1 cost in my state — usually has a national answer and a local one, and people search for the wrong half.
Manufacturer self-pay pricing does not change by state. $349 for the standard pen, $149 to $299 for the tablet, everywhere. What changes is coverage: whether your state's Medicaid programme covers the obesity indication as opposed to the diabetes one, whether your employer bought a benefit that includes weight-loss drugs, and which telehealth prescribers hold a licence where you live.
Two neighbours with different employers routinely face completely different costs in the same city. Full breakdown: GLP-1 cost by state.
Filed by the Peptides Editorial research desk. Corrections: the corrections log.